Cargando…

A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression

BACKGROUND: Depressed patients who initially fail to achieve remission when placed on a selective serotonin reuptake inhibitor (SSRI) may require a second treatment. OBJECTIVES: The purpose of this study was to evaluate the effectiveness, cost, cost-effectiveness, and budget impact of second-line ph...

Descripción completa

Detalles Bibliográficos
Autor principal: Malone, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2007
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437458/
https://www.ncbi.nlm.nih.gov/pubmed/17874482
http://dx.doi.org/10.18553/jmcp.2007.13.s6-a.8